Last reviewed · How we verify
NCT05310994
Efficacy Evaluation of Wasabi Leaf Extract on Skin
NA trial testing Placebo drink in Skin Condition in 50 participants. Completed in 31 July 2022.
15 June 2022
Quick facts
| Lead sponsor | TCI Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 28 March 2022 |
| Primary completion | 15 June 2022 |
| Estimated completion | 31 July 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Placebo drink — full drug profile →
- Wasabi Leaf Extract Drink
Conditions studied
- Skin Condition — all drugs for Skin Condition →
Sponsor
TCI Co., Ltd. — full company profile →
Who can join
Adults 20 to 65, any sex, with Skin Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the efficacy of Wasabi Leaf Extract on skin
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Harnessing Nature's Toolbox: Naturally Derived Bioactive Compounds in Nanotechnology Enhanced Formulations.
Sanjai C, Gaonkar SL, Hakkimane SS. · · 2024 · cited 10× · PMID 39494011 · DOI 10.1021/acsomega.4c07756 -
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT05310994
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Condition
Currently open trials in the same condition.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT06775132 — Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes · recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
- NCT06724627 — Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting · NA · recruiting
- NCT06157567 — Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System · NA · active not recruiting
Other TCI Co., Ltd. trials
Trials by the same sponsor.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT07302828 — Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sache · NA · completed
- NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting
- NCT07097987 — Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion · NA · not yet recruiting
- NCT07097974 — Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05310994 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TCI Co., Ltd.
- Last refreshed: 29 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05310994.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing